Related Experiment Video

Updated: Mar 18, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Small cell lung cancer: Time to revisit DNA-damaging chemotherapy

Anish Thomas1, Yves Pommier2

  • 1Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. anish.thomas@mail.nih.gov pommier@nih.gov.

Science Translational Medicine
|July 8, 2016
PubMed

Insights

Rational use of DNA-damaging chemotherapy, with new combinations to heighten DNA replication stress, could improve outcomes in small cell lung cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Small cell lung cancer (SCLC) remains a challenging diagnosis with limited treatment options.
  • DNA-damaging chemotherapy is a cornerstone of SCLC treatment.
  • Enhancing DNA replication stress is a potential strategy to overcome treatment resistance.

Purpose of the Study:

  • To explore the potential of novel chemotherapy combinations to increase DNA replication stress in SCLC.
  • To evaluate the impact of heightened DNA replication stress on treatment outcomes in SCLC.

Main Methods:

  • Review of existing literature on SCLC chemotherapy and DNA replication.
  • Analysis of preclinical data on drug combinations targeting DNA replication.
  • Discussion of potential clinical trial designs.

Main Results:

  • Certain chemotherapy combinations show promise in inducing significant DNA replication stress.
  • Heightened replication stress may lead to increased cancer cell death in SCLC models.
  • Further research is warranted to validate these findings in clinical settings.

Conclusions:

  • Strategic combinations of DNA-damaging agents could represent a promising therapeutic approach for SCLC.
  • Inducing DNA replication stress is a viable strategy to improve SCLC treatment efficacy.
  • Future clinical investigations are crucial to translate these findings into improved patient outcomes.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K